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Abstract Lichtheimia corymbifera and Aspergillus
flavus pulmonary coinfection has been rarely reported
in immune-competent patients. We report case of a
young male who presented with clinical features of
pulmonary-renal syndrome and was later diagnosed to
have bilateral polymicrobial fungal lung infection.
Keywords Lichtheimia corymbifera  Aspergillus
flavus  Coinfection  Invasive mycosis

these cases have varied from poorly controlled
diabetes, chronic steroid use, leukemia, HIV and
cardiac transplant [2–7]. Agents of mycosis reported
in dual infections have been Aspergillus fumigatus,
Aspergillus flavus, Aspergillus alliaceus, Mucor
species, Lichtheimia corymbifera, mucoraceous mold
(not speciated). Patient outcome with fungal coinfection has been poor with high mortality rates [2–7].

Case Report
Introduction
Invasive fungal infections have remained a major
cause of morbidity and mortality in immunocompromised individuals, particularly those with hematological malignancies, solid organ transplant and
neutropenia [1]. Polymicrobial pulmonary fungal
infection is a rare entity reported mainly in severely
immunodeficient patients [2–7]. Aspergillus species
and mucoraceous molds have been implicated mainly
as a cause of coinfection. Underlying risk factors in
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A 45-year-old male with no prior comorbid presented
to the Emergency department with history of productive cough, high grade fever and dyspnea for a week
and submassive hemoptysis for past one day. There
was no history of smoking, and he denied history of
other substance abuse. His past, family and drug
history was not significant. He had no history of any
previous infections or surgical intervention. On physical examination, he was awake and alert, had a pulse
of 118 beats per minute, respiratory rate of 32 breaths
per minute and blood pressure of 140/90 mmHg and
was afebrile at the time of examination in emergency
room. Blood oxygen saturation was 91% on 5 l of
oxygen. On chest auscultation, there were bilateral
coarse crackles till mid lung zones. Cardiovascular,
abdominal and neurological examination was normal.
Laboratory data revealed creatinine of 3.5 mg/dl,
blood urea of 96 mg/dl and WBC count of
23 9 109/l. His blood sugars were normal. Chest
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radiograph showed bilateral alveolar infiltrates which
were denser in lower lung zones (Fig. 1). Blood and
sputum cultures were obtained, and he was treated as
severe community acquired pneumonia with imipenem, vancomycin and levofloxacin.
The chest X-ray and hypoxemia worsened within
24 h of admission requiring intubation and transfer to
the intensive care unit. High-resolution CT of the chest
and abdomen without contrast showed multiple patchy
areas of consolidation and ground glass opacities in
both lungs with underlying cystic and cavitary
changes without mediastinal or hilar lymphadenopathy or pleural effusion (Fig. 2), while the abdominal
examination was reported as normal. Intravenous
contrast was not given due to deranged renal parameters. Bronchoscopy revealed inflamed bronchial
mucosa and blood in the right bronchial tree. Multiple
urinalyses showed microscopic hematuria and no red
blood cell casts. A clinical diagnosis of pulmonaryrenal syndrome was made due to rapid deterioration of
both respiratory and renal functions. Sequential
bronchial lavage was not done due to high oxygen
requirement. Nephrology and Infectious Disease consult was obtained, and they agreed with the diagnosis
of pulmonary-renal syndrome. He was commenced on
intravenous pulse steroids along with plasmapheresis.
Meanwhile microscopic examination of bronchoalveolar lavage (BAL) in mycology laboratory
and cytopathology revealed presence of septate
hyphae. Aseptate hyphae were not seen on initial
microscopic examination. Gram, acid fast and

Fig. 1 Chest X-ray on admission showing bilateral alveolar
lung infiltrates that are more dense in lower lung zones
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Fig. 2 Coronal and axial views of high-resolution CT of the
chest (HRCT) show multiple patchy areas of consolidation and
ground glass opacities in both lungs with underlying cystic and
cavitary changes

immunofluorescent stain for Pneumocystis jirovecii
were negative. Based on microscopic findings, the
patient was started on amphotericin B. Bacterial and
fungal cultures were set up in the laboratory; for
fungi, Sabouraud dextrose agar plates were incubated
at 25 and 37 °C, potato agar and Mycosel agar were
also used for fungal growth. For bacterial growth,
chocolate, sheep blood and MacConkey’s agars were
used and incubated at 36 °C for 48 h. There was
growth of two types of molds on all non-selective
plates and no bacterial growth 48 h later. These two
molds were phenotypically identified 72 h later as L.
corymbifera and A. flavus. At this point, voriconazole
was added to the regimen, and steroids and
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plasmapheresis were stopped. Laboratory results of
ANA, anti-dsDNA, c-ANCA, p-ANCA, (done by
ELISA, DiaSorin, Italy), HIV, Hepatitis B and C
virus were reported as negative. Bacterial and
mycobacterial cultures in BAL were finally reported
as negative. Blood cultures; the first set drawn before
the administration of antibiotics and urine cultures
were also reported as negative for any bacterial or
fungal pathogens. The antibacterial drugs were
stopped on day seven.
Patient eventually improved and was extubated
after two days of ICU stay. His creatinine levels were
normal (1 mg/dl) when he was shifted out of the ICU.
The steroids were gradually tapered off. He was sent
home in a stable clinical state without supplemental
oxygen. The lung infiltrates on chest radiograph had
completely resolved and renal function improved on a
clinic follow-up after 2 weeks of hospital discharge
(Fig. 3).

Microbiological Diagnosis
Fungal and bacterial cultures were performed using
standard methodology [8]. After 24 h of incubation
culture plates inoculated with BAL revealed abundant
growth of whitish floccose colonies typical of a
mucoraceous with a colorless reverse. Growth of a
second type of mold with flat, granular, greenish
colonies was also noted in Sabouraud dextrose agar

Fig. 4 Microscopic morphology of Lichtheimia corymbifera
(a) and Aspergillus flavus (b). a Broad ribbon-like aseptate
hyphae and sporangium of Lichtheimia corymbifera. b Thin,
septate hyphae and head of Aspergillus flavus (arrow)

(both plates incubated at 25 and 37 °C), potato agar (to
induce sporulation), blood and chocolate agar plates.
Identification was made on the basis of gross appearance of colonies on plates and microscopic examination. Aspergillus flavus was identified by the presence
of typical rough conidiophore, uniseriate and biseriate
phialides covering entire vesicles (Fig. 4a) [9].
Lichtheimia corymbifera was identified on the basis
of typical colony morphology, branching sporangiophore bearing small sporangia with funnel-shaped
bases and a conical columella (Fig. 4b) [9].

Discussion
Fig. 3 Chest X-ray after 3 weeks of antifungal treatment
showing complete resolution of lung infiltrates

Invasive pulmonary mycosis has been rarely reported
in patients with no apparent risk factors [10–16]. In
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most instances, extensive environmental exposure to
fungal spores during occupational or recreational
activities has been identified as an initiating event.
Mixed pulmonary mycosis due to A. fumigatus and
Rhizopus species in a previously healthy patient has
reported in one patient with after near drowning [17].
This patient had a history of aspiration of muddy water
after being submerged for several minutes. In addition
to fungi, multiple bacteria were also isolated from
sputum and bronchoalveolar lavage of this patient.
Patient recovered fully with prolonged treatment with
liposomal amphotericin B. Another report also highlighted invasive fungal infection with pulmonary
involvement due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient. This
patient had a history of trauma and was successfully
treated by multiple surgical debridement and liposomal amphotericin B [18]. In contrast, in our patient
exposure to soil or dust or trauma was not found. An
extensive workup for immunodeficiency was not done
as his previous history was unremarkable for recurrent
infections. His blood glycemic levels remained normal
throughout the course of treatment despite being in
severe sepsis hence HbA1C levels were never
obtained.
Diagnosis of invasive mycosis is challenging due to
low sensitivity of currently available diagnostic
modalities. Culture and histopathology require invasive sampling approaches such as bronchoscopy with
BAL, transbronchial lung biopsy, computed tomographic-guided transthoracic needle biopsy and videoassisted thoracoscopic surgery may be required to
make a diagnosis. Classic signs and patterns on
radiology for invasive mycosis, although are well
documented for immunocompromised patient but are
less commonly seen and reported in immunocompetent individuals [19]. Antigen detection and PCRbased methods are usually not available in settings
with limited resources. All these factors lead to either
misdiagnosis or a delayed diagnosis in immunocompetent patients.
In our patient, culture and microscopy of the BAL
fluid yielded growth of A. flavus and L. corymbifera.
Both of these fungi are a common cause of invasive
mycosis and have been reported to cause illness in
immune compromised as well as immune-competent
patients. Drug of choice to treat invasive pulmonary
aspergillosis is voriconazole and for pulmonary
mucormycosis is amphotericin B [19]. In our patient,
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amphotericin B was started after the microscopy and
cytology report and voriconazole was subsequently
added to this regimen. The patient improved on this
therapy with complete resolution of lung infiltrates in
two weeks. The deranged renal function was likely due
to acute renal injury secondary to sepsis which led to
the presentation similar to pulmonary-renal syndrome.
The use of corticosteroids in this case was justified due
to high suspicion of life-threatening vasculitis which
later turned out to be a fungal infection. To our
knowledge, pulmonary coinfection with A. flavus and
L. corymbifera in an immunocompetent patient presenting as a pulmonary-renal syndrome has not been
reported previously. Clinicians should be aware of
such cases for prompt appropriate diagnosis and
management.
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